The US Netherton Syndrome Market represents a particularly important component of North America's growth, supported by awareness initiatives, drug-development programs, clinical research, and regulatory incentives for rare pediatric diseases. The incidence of Netherton syndrome in the US is estimated at approximately 1 to 2 cases per 200,000 live births, highlighting the importance of...